Catalyst Wire Dossier Catalyst Wire Dossier

Ursodeoxycholic acid (UDCA)

ursodeoxycholic acid
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ursodeoxycholic acid (UDCA), covering 2014-03-24 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia [NA]

See pricing